Does RELUGOLIX Cause Prostate cancer? 152 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 152 reports of Prostate cancer have been filed in association with RELUGOLIX (Orgovyx). This represents 0.7% of all adverse event reports for RELUGOLIX.
152
Reports of Prostate cancer with RELUGOLIX
0.7%
of all RELUGOLIX reports
36
Deaths
22
Hospitalizations
How Dangerous Is Prostate cancer From RELUGOLIX?
Of the 152 reports, 36 (23.7%) resulted in death, 22 (14.5%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Prostate cancer Listed in the Official Label?
Yes, Prostate cancer is listed as a known adverse reaction in the official FDA drug label for RELUGOLIX.
What Other Side Effects Does RELUGOLIX Cause?
Hot flush (6,845)
Fatigue (5,203)
Therapy interrupted (3,251)
Incorrect dose administered (1,917)
Asthenia (1,718)
Arthralgia (1,385)
Diarrhoea (1,383)
Product dose omission issue (1,189)
Dizziness (1,146)
Constipation (902)
What Other Drugs Cause Prostate cancer?
RANITIDINE (60,641)
LEUPROLIDE (1,736)
ABIRATERONE (661)
ENZALUTAMIDE (642)
ADALIMUMAB (573)
ETANERCEPT (482)
METHOTREXATE (444)
INFLIXIMAB (376)
LENALIDOMIDE (366)
PREDNISONE (317)
Which RELUGOLIX Alternatives Have Lower Prostate cancer Risk?
RELUGOLIX vs REMDESIVIR
RELUGOLIX vs REMERON
RELUGOLIX vs REMICADE
RELUGOLIX vs REMIFENTANIL
RELUGOLIX vs REMIMAZOLAM